Wu, Chuanbin
Jinan University,
China
2025 Rank: 85,971
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 546 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85,971 | 90,031 |
| Total Cites | 2,111 | 2,284 |
| H-index | 19 | 21 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 9 | 9 |
| Number of Single+First+Last Authored Papers | 211 | 211 |
| Total Cites to Single+First+Last Authored Papers | 1,350 | 1,417 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,771 | 1,812 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.26 |
| Self-Citation Percentage |
7.57%
|
|
Wu, Chuanbin
Jinan University,
China
2024 Rank: 75,081
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 422 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75,081 | 82,758 |
| Total Cites | 1,784 | 1,942 |
| H-index | 20 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 12 | 12 |
| Number of Single+First+Last Authored Papers | 210 | 210 |
| Total Cites to Single+First+Last Authored Papers | 1,240 | 1,331 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,460 | 1,508 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.29 |
| Self-Citation Percentage |
8.14%
|
|
Wu, Chuanbin
Jinan University,
China
2023 Rank: 79,699
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 507 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79,699 | 88,928 |
| Total Cites | 1,553 | 1,666 |
| H-index | 17 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 19 | 19 |
| Number of Single+First+Last Authored Papers | 208 | 208 |
| Total Cites to Single+First+Last Authored Papers | 1,147 | 1,232 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,257 | 1,289 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
6.78%
|
|
Wu, Chuanbin
Jinan University,
China
2022 Rank: 156,584
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1,151 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 156,584 | 148,237 |
| Total Cites | 1,086 | 1,233 |
| H-index | 14 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 6 | 6 |
| Number of Single+First+Last Authored Papers | 198 | 198 |
| Total Cites to Single+First+Last Authored Papers | 793 | 902 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 896 | 948 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.30 |
| Self-Citation Percentage |
11.92%
|
|
Wu, Chuanbin
Jinan University,
China
2021 Rank: 163,676
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1,237 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 163,676 | 161,417 |
| Total Cites | 1,363 | 1,524 |
| H-index | 16 | 18 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 17 | 17 |
| Number of Single+First+Last Authored Papers | 175 | 175 |
| Total Cites to Single+First+Last Authored Papers | 1,001 | 1,109 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,144 | 1,217 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.25 |
| Self-Citation Percentage |
10.56%
|
|
Wu, Chuanbin
Sun Yat-Sen University,
China
2020 Rank: 148,348
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1,007 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148,348 | 165,053 |
| Total Cites | 801 | 912 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 27 | 27 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 590 | 679 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 717 | 765 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.19 |
| Self-Citation Percentage |
12.17%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.